Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced that Phase I/II clinical data for its Smac mimetic drug candidate birinapant (formerly TL32711) were presented at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO).
Help employers find you! Check out all the jobs and post your resume.
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced that Phase I/II clinical data for its Smac mimetic drug candidate birinapant (formerly TL32711) were presented at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO).
Help employers find you! Check out all the jobs and post your resume.
